Physician

Matthew Helm, MD

According to 2025 Medicare claims, Matthew Helm, MD (NPI: 1346583150) practices dermatology in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is PDP OF TEXAS, PLLC (NPI: 1629025739; TIN: 752286998) and primary practice location at 75090-5000.

Helm's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 827 traditional Medicare patients, billed 5,523 HCPCS/CPT codes, and received $366,286 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 931 prescription claims across 389 beneficiaries totaling $562,461 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 64 records totaling $1,623. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $44,858 and ending at $366,286. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $26,397 to $562,461. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$307K$614K2017 Medicare payment: $44,858 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $155,126 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $385,747 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $392,089 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $614,446 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $528,848 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $258,839 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $366,286 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017297974$44,858
20186803,385$155,126
20191,65710,316$385,747
20201,4039,717$392,089
20211,27710,554$614,446
20221,3159,789$528,848
20238574,963$258,839
20248275,523$366,286

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$281K$562K2015 Drug cost: $26,397 (USD; Tot_Drug_Cst)2016 Drug cost: $34,311 (USD; Tot_Drug_Cst)2017 Drug cost: $26,248 (USD; Tot_Drug_Cst)2018 Drug cost: $37,469 (USD; Tot_Drug_Cst)2019 Drug cost: $305,192 (USD; Tot_Drug_Cst)2020 Drug cost: $504,133 (USD; Tot_Drug_Cst)2021 Drug cost: $526,693 (USD; Tot_Drug_Cst)2022 Drug cost: $457,709 (USD; Tot_Drug_Cst)2023 Drug cost: $273,233 (USD; Tot_Drug_Cst)2024 Drug cost: $562,461 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201588162$26,397
201694272$34,311
2017164358$26,248
2018268637$37,469
20195411,090$305,192
20204981,152$504,133
20214471,121$526,693
20224541,118$457,709
2023366858$273,233
2024389931$562,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths277331$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more376475$66
11102Biopsy of related skin growth, first growth250300$62
17000Destruction of precancer skin growth, 1 growth412562$34
17003Destruction of precancer skin growth, 2-14 growths3242,179$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz AutoinjectorIxekizumab15420$106,087
Dupixent PenDupilumab17392$67,787
Clobetasol PropionateClobetasol Propionate1684,990$5,455
FluorouracilFluorouracil31789$2,412
Triamcinolone AcetonideTriamcinolone Acetonide1494,357$2,308

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.64$1,623ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Helm, MD?

Tedicare shows public-source Medicare data for Matthew Helm, MD (NPI 1346583150), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Helm, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Helm, MD?

Matthew Helm, MD is linked to PDP OF TEXAS, PLLC (billing NPI 1629025739) in the available physician profile data.

Does Matthew Helm, MD have Open Payments data?

Matthew Helm, MD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.